绿康生化(002868) - 2024 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2024 was ¥145,575,505.10, a decrease of 13.16% compared to the same period last year[3]. - The net profit attributable to shareholders was -¥69,903,697.48, down 77.35% year-on-year[3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥72,287,556.33, a decline of 89.90% compared to the previous year[3]. - The basic earnings per share for Q3 2024 was -¥0.45, a decrease of 73.08% year-on-year[3]. - The weighted average return on equity was -23.37%, a decline of 15.94% compared to the same period last year[3]. - The company reported a net loss of ¥303,864,257.20 for the period, compared to a loss of ¥146,882,065.02 in the same quarter last year[16]. - The net profit for Q3 2024 was -157,558,109.74 CNY, compared to -86,624,964.66 CNY in the same period last year, representing a significant increase in losses[18]. - The basic and diluted earnings per share for the current period were -1.01 CNY, compared to -0.56 CNY in the previous period[19]. - The total comprehensive income for the period was -157,558,109.74 CNY, compared to -86,624,964.66 CNY in the previous year[18]. - The company reported a total operating profit of -187,414,889.06 CNY, worsening from -83,872,043.12 CNY year-over-year[18]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,700,472,574.81, representing a decrease of 13.46% from the end of the previous year[3]. - Total assets decreased to ¥1,700,472,574.81 from ¥1,965,009,357.76 year-over-year, reflecting a decline of 13.5%[16]. - Total liabilities amounted to ¥1,441,635,902.35, down from ¥1,550,898,558.00, indicating a reduction of 7.0%[16]. - Shareholders' equity attributable to the parent company was ¥256,578,585.48, down 37.62% from the end of the previous year[3]. - The total equity attributable to shareholders decreased to ¥256,578,585.48 from ¥411,287,522.61, a decline of 37.6%[16]. Cash Flow - Cash flow from operating activities for the year-to-date was ¥112,345,312.16, an increase of 191.67% year-on-year[3]. - Cash flow from operating activities generated a net amount of 112,345,312.16 CNY, a recovery from a negative cash flow of -122,560,703.12 CNY in the previous year[20]. - Total cash inflow from investing activities was 145,945,581.97 CNY, down from 296,250,956.38 CNY in the previous year[21]. - Cash flow from financing activities resulted in a net outflow of -138,725,363.02 CNY, contrasting with a net inflow of 440,797,609.14 CNY in the same period last year[21]. - Cash and cash equivalents at the end of the period were 14,522,191.95 CNY, a decrease from 220,317,856.07 CNY at the end of the previous year[21]. - Cash and cash equivalents decreased to 14,522,191.95 RMB from 84,384,803.39 RMB[14]. Expenses - The company reported a significant increase in management expenses, which rose by 83.93% to ¥34,671,203.19 due to increased personnel costs and asset depreciation[7]. - Financial expenses surged by 151.08% to ¥50,788,079.50, primarily due to interest expenses from project loans and increased discounting costs[7]. - Total operating costs for Q3 2024 were ¥614,888,371.22, up 30.3% from ¥471,642,652.69 in the previous year[17]. - Research and development expenses increased to ¥30,014,022.67, a rise of 52.5% from ¥19,620,456.15 in Q3 2023[17]. - The company incurred asset impairment losses of 66,786,072.89 CNY, compared to 32,405,786.76 CNY in the previous year[18]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 9,989[8]. - Shanghai Kangyi Investment Co., Ltd. holds 30.43% of shares, totaling 47,291,400 shares, with 6,830,000 shares pledged[8]. - The company has not disclosed any known relationships or concerted actions among the top shareholders[9]. Stock Issuance - The company plans to issue stocks to specific targets through a simplified procedure, approved by the board on April 28, 2024[11]. - The company held a board meeting on July 22, 2024, to review the stock issuance plan[12]. Current Assets - The company reported a significant decrease in current assets, with total current assets at 237,389,066.41 RMB, down from 478,385,975.15 RMB[14]. - Accounts receivable decreased to 62,236,701.53 RMB from 86,059,203.01 RMB[14]. - Inventory decreased to 127,610,433.96 RMB from 201,894,404.60 RMB[14]. - Long-term equity investments increased to 21,110,645.71 RMB from 20,329,984.83 RMB[14]. - The company's goodwill remained stable at ¥61,603,281.45, unchanged from the previous year[16]. - Deferred tax assets increased to ¥59,659,317.77 from ¥30,956,411.17, showing a growth of 92.7%[16].